APOMORPHINE VIATRIS 5 mg/ml, solution for injection 10 ampoules of 10 ml
Active ingredients: Apomorphine hydrochloride hemihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 ampoules of 10 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- APOMORPHINE VIATRIS 5 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 10 ampoule(s) en verre de 10 ml
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Nov 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63665248CIP73016934CIP133400930169346Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'APOMORPHINEsolution | 5 mg · 1 mL de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.